Abstract:Several immune cell populations participate in the development of radiation-induced cardiac fibrosis. However, the underlying mechanism remains to be elucidated. Male C57BL/6 mice (8-12 weeks old) were anesthetized and exposed to a single cardiac radiation dose of 20 Gy using the small-animal radiation research platform. We conducted echocardiography and histological analysis to identify cardiac fibrosis from a functional and pathological perspective. Time-of-flight mass cytometry (CyTOF) was used to describe the compositional changes of immune cells 1, 4, and 8 weeks after cardiac irradiation in mouse peripheral blood and cardiac tissue samples. Real-time quantitative polymerase chain reaction (RT-qPCR) was used to measure CD14 and CD105 mRNA levels from peripheral blood cells in eight patients who received thoracic radiotherapy 6 months ago. We observed reduced cardiac systolic function and increased collagen deposition in cardiac tissue after irradiation. Transforming growth factor-R, tumor necrosis factor-alpha, and interleukin-6 expression significantly elevated in the plasma. We identified a significant increase in CD45+ immune cell levels four weeks after cardiac irradiation using CyTOF, and neutrophil, monocyte, and macrophage levels elevated in blood samples after cardiac irradiation (four weeks). In cardiac tissue samples, monocyte and macrophage levels increased after cardiac irradiation (four weeks) compared with control group. Macrophages and monocytes were further analyzed, and the proportion of Ly6ChiCD103+ myeloid cells increased after cardiac irradiation in tissue samples (four weeks). RTqPCR revealed that CD14 expression was higher in patients with cardiac injured group than in the control group (Previous studies reported that Ly6Chi monocytes in mice are similar to CD14 + CD16- monocytes in humans). We found that Ly6ChiCD103+ myeloid cells are critical subsets in radiation-induced cardiac fibrosis and might play protective roles in the process. Ly6ChiCD103+ myeloid cells may be considered an early biomarker for detecting radiation-induced cardiac fibrosis.

Research Progress on Radiation-Induced Heart Damage——basic Mechanism

New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease

Research Progress on Cardiac Injury from Breast Cancer Radiation Therapy

Radiation-induced Damage to Cardiac Substructures in Breast Cancer Patients and the Protective Strategies

Preclinical research into basic mechanisms of radiation-induced heart disease

Radiation-induced heart disease in lung cancer radiotherapy: A dosimetric update

Relationship Between Heart Irradiation Dose-volume and Radiation-induced Cardiac Toxicity in Radiotherapy for Thoracic Neoplasms

Advancements in Radiation-Induced Heart Disease Diagnosis and Treatment

Research Progress on the Mechanism, Monitoring, and Prevention of Cardiac Injury Caused by Antineoplastic Drugs—Anthracyclines

Pathogenesis and Prevention of Radiation-induced Myocardial Fibrosis

Radiation-induced heart disease: a review of classification, mechanism and prevention

Research Progress in Pathogenesis of Myocardial Fibrosis in Radiation-Induced Heart Damage

Radiation-induced heart disease: pathologic abnormalities and putative mechanisms

Radiotherapy-induced heart disease: a review of the literature

Potential markers and metabolic processes involved in the mechanism of radiation-induced heart injury

Research Progress of Radiation Induced Atherosclerosis

Fullerenols Mitigate Radiation‐Induced Myocardial Injury

Radiation therapy in the thoracic region: Radio-induced cardiovascular disease, cardiac delineation and sparing, cardiac dose constraints, and cardiac implantable electronic devices

Administration of Trastuzumab with Heart Irradiation Induced Acute Cardiotoxicity in Mice.

The Role of Mitochondrial Dysfunction in Radiation-Induced Heart Disease: From Bench to Bedside

Uncovering the Connection Between Ly6c Hi Cd103 + Myeloid Cells and Radiation-Induced Cardiac Fibrosis by Cytof